Exelixis Inc (NAS:EXEL)
$ 56.51 -0.60 (-1.05%) Market Cap: 14.20 Bil Enterprise Value: 13.59 Bil PE Ratio: 18.77 PB Ratio: 7.40 GF Score: 92/100

Exelixis Inc at Jefferies Global Healthcare Conference in New York Transcript

Jun 3, 2026 / 03:05 PM GMT
Release Date Price: $51.6 (+6.30%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EXEL.OQ - Exelixis Inc
Exelixis Inc at Jefferies Global Healthcare Conference in New York
Jun 03, 2026 / 03:05PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Well, good morning, everyone. I really do appreciate it. My name is Akash Jawari. I head our performant biotech efforts on the research side here at Jefferies and I have the pleasure of hosting the Exelaxis management team, which again is a commercial stage company that is in several different tumor types and is a leader. Kind of in renal carcinoma, but then also has ambitions to really think about VEGF inhibition in a broader subset of diseases and that's what they're explaining, looking at with Zanza.

Andrew, why don't I hand it off to you for some intro remarks and then we'll get started.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot